Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women (Q36761442)

16 August 2017

1 reference

title

Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women (English)

1 reference

16 August 2017

Preston RA

1

1 reference

16 August 2017

publication date

1 February 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

10 Suppl 1

1 reference

16 August 2017

page(s)

32-41

1 reference

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Blood pressure and the global burden of disease 2000. Part 1: estimates of blood pressure levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Postovariectomy hypertension is linked to increased renal AT1 receptor and salt sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Novel mechanisms responsible for postmenopausal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Postmenopausal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Surgical menopause increases salt sensitivity of blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Management of prehypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Impact of high-normal blood pressure on the risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Feasibility of treating prehypertension with an angiotensin-receptor blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Mineralocorticoid Blockade Reduces Vascular Injury in Stroke-Prone Hypertensive Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Aldosterone in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Aldosterone antagonist improves diastolic function in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Effect of hormone therapy on BP in normotensive and hypertensive postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Estrogen plus progestin and the risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

The postmenopausal estrogen/progestin interventions study: primary outcomes in adherent women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Drospirenone: pharmacology and pharmacokinetics of a unique progestogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

The novel progestin drospirenone and its natural counterpart progesterone: Biochemical profile and antiandrogenic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Additive effect of drospirenone/17-beta-estradiol in hypertensive postmenopausal women receiving enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Evidence-based guidelines for cardiovascular disease prevention in women 11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, p

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13697130601114909

10.1080/13697130601114909

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference